T he metabolic enzyme IDO1 contributes to the balance between tolerance vs inflammation in a number of experimental models. Expression of IDO1 in APCs, such as macrophages and dendritic cells, can suppress T cell responses as observed during mammalian pregnancy, inflammatory conditions, autoimmunity, and tumor resistance (1) (2) (3) (4) (5) (6) . IDO1 is itself modulated in the presence of inflammatory stimuli, exhibiting strong induction in response to both IFN and TLR signaling (7, 8) . This enzyme catabolizes the essential amino acid tryptophan, thus decreasing concentrations in the local microenvironment as well as generating biologically active downstream metabolites (9, 10) . While either of these pathways may operate to regulate T cells, the existing evidence suggests that both mechanisms are required to achieve the optimal effect (11) .
The ability to sense and respond to decreasing concentrations of amino acids is an important cellular survival mechanism, and the pathways that mediate this effect are well conserved. Studies in both yeast and mice revealed that the protein kinase general control nonderepressible-2 (GCN2) 3 plays a central role in the response to amino acid deprivation (12, 13) . This kinase undergoes a change in activation status upon binding to uncharged tRNAs that accumulate during cellular starvation (14, 15) . The sole identified target of GCN2 is the translation initiation factor, eukaryotic initiation factor 2␣ (eIF2␣) (16) . Phosphorylation of eIF2␣ mediates inhibition of global protein synthesis, but paradoxically increases the translation of activating transcription factor 4 (13, 17) . Activating transcription factor 4, along with other selected transcriptional regulators, then activates the genetic program required to achieve cellular homeostasis (18) .
The importance of GCN2 during the T cell response to tryptophan depletion has been established. T cells from GCN2-deficient mice are refractory to IDO1-mediated suppression of proliferation in vitro and induction of anergy in vivo (19) . There is also accumulating evidence that GCN2 activation plays a role in the IDO1-expressing APCs themselves. For example, a recent report demonstrated that IDO1 and GCN2 regulate autocrine IFN-␣-driven amplification of IDO1 expression in plasmacytoid dendritic cells (20) . GCN2 belongs to a family of kinases that phosphorylate eIF2␣ in response to diverse forms of cellular stress (21) . Hemeregulated inhibitor (HRI) is activated by oxidative stress and hemoglobin levels during erythrocyte maturation, protein kinase R by dsRNA, and the endoplasmic reticulum (ER) resident homolog of protein kinase R, protein kinase-like ER kinase (PERK), is activated during the unfolded protein response (22) (23) (24) . We have previously shown that pharmacological activators of PERK upregulate B lymphocyte-induced maturation protein-1 (BLIMP-1) in cells of the myeloid lineage (25) . Furthermore, BLIMP-1 was originally identified as a postinduction transcriptional repressor of IFN-␤ in response to intracellular dsRNA accompanying viral infection (26, 27) . These data suggest that BLIMP-1 may be a common target of stress-induced signaling pathways. In turn, the induction of BLIMP-1 may shape the outcome of the integrated stress response by altering gene expression.
BLIMP-1 is a Krüppel-type zinc-finger protein that exhibits preferential binding to sequences with a high degree of overlap with the IFN regulatory factor-element (IRF-E) found in promoters responsive to IFN-␥ (28, 29) . Work from our laboratory has shown that BLIMP-1 is indeed capable of repressing genes regulated by IFN-␥ (30, 31) . In these examples, BLIMP-1 mediates repression through direct competition with IFN regulatory factors (IRFs) at the IRF-E sites contained within their promoters. However, BLIMP-1 can also exert its repressive effect through the recruitment of histone-modifying enzymes (27, (32) (33) (34) (35) . Thus, BLIMP-1 has the potential to either transiently repress its targets or to alternatively ensure stable epigenetic silencing.
The IDO1 promoter is highly responsive to IFN-␥ and is rapidly induced in cell lineages in which BLIMP-1 is also expressed. A structurally similar enzyme encoded by IDO2 can also be induced by IFN-␥, but the regulatory elements conferring this response have not been characterized (36 -39) . In this study we tested the hypothesis that BLIMP-1 operates as a postinduction repressor during IDO1-mediated immunoregulation, much like its originally described function limiting IFN-␤ production during viral infection. We propose that BLIMP-1 regulates IDO1 levels in cell types that express these two proteins, thereby maintaining the expression of IDO1 at a level that successfully balances the outcome of tolerance vs inflammation.
Materials and Methods

Cell culture
U937, H929, U266 and HeLa cell lines were maintained in RPMI 1640 growth medium supplemented with 10% heat-inactivated FCS. COS7 cells were maintained in DMEM medium supplemented with 10% FCS. Tryptophanol, L-tryptophan, DTT, PMA, and recombinant human IFN-␥ and IFN-␣ were all purchased from Sigma-Aldrich and added directly to the growth media in the indicated final concentrations. Tryptophan-depleted media was generated by transfecting HeLa cells with an IDO1 expression vector and cultured for 40 h. Media was filtered before secondary cell culture and supplemented with 10ϫ concentration of L-tryptophan where shown. The use of peripheral blood from healthy donors was approved by the Local Research Ethics Committee. Primary monocytes were isolated by negative selection using a monocyte-specific magnetic bead protocol (Miltenyi Biotec). Purity was monitored by flow cytometry using CD14 and CD11b monocyte-macrophage markers. Human monocytes were maintained in RPMI 1640 supplemented with 30% heat-inactivated AB human serum, 100 g/ml streptomycin, and 100 U/ml penicillin and adhered overnight for 16 h before stimulation.
Expression vectors and transfections
Expression vectors encoding full-length (FL) BLIMP-1, IRF-1, and IRF-2 have been described previously (30) . An expression vector encoding IDO1 was generated by amplifying cDNA using primers (5Ј-ATAGAATTCG CCACCATGGCACACGCTATGGA-3Ј and 5Ј-ATATGTCGACTTAACC TTCCTTCAAAA-3Ј) and cloned into the modified pIRES2-EGFP vector incorporating an N-terminal Myc epitope tag as previously described (30) . Transfection of HeLa and COS7 cells were performed with GeneJuice reagent according to the manufacturer's instructions. In RNA interference experiments, U937 cells were transfected with 400 pmol of small interfering RNA (siRNA) by electroporation with settings of 280 V and 975 F. Forty hours posttransfection, cells were processed for protein and mRNA evaluation. The oligos used contained the following sequences: GCN2 siRNA sense sequence (5Ј-CAGCAGAAAUCAUGUACGAUU-3Ј); control siRNA sense sequence (5Ј-CUACCUCUAGAACGGACGUUU-3Ј).
HPLC analysis
Tryptophan (Sigma-Aldrich, catalog no. T-0254) was dissolved in water and the concentration accurately determined by UV absorbance spectrophotometry. A dilution series was then prepared in acetic acid (1% v/v) from 50 to 0.1 g/ml. Standards and media samples were analyzed by HPLC on a C18 column (Agilent Zorbax ODS, 4.6 ϫ 250 mm) using a Dionex HPLC. An elution gradient was used from 100% eluent A (methanol 2.5% v/v, isopropanol 2.5% v/v, trifluoroacetic acid 0.1% v/v) to 100% eluent B (methanol 47.5% v/v, isopropanol 47.5% v/v, trifluoroacetic acid 0.1% v/v) at 20°C with a 0.5 ml/min flow rate. The column eluate was monitored by UV absorbance at multiple wavelengths (230, 260, and 278 nm) using a Dionex PDA100 detector to aid peak identification. Eluates were also analyzed using an in-line RF 2000 fluorescence detector with 280 and 340 nm excitation and emission wavelengths. Fluorescence detector gain settings were chosen to give more sensitive detection of tryptophan in more dilute samples than was possible using UV absorbance. Concentrations of tryptophan in media samples were determined from a calibration curve based on the peak area (calculated using Dionex Chromeleon software) for absorbance at 278 nm or the fluorescence emission at 340 nm depending on the concentration.
RT-PCR
RNA was isolated by the TRIzol method (Invitrogen) and subjected to DNase I treatment (DNA-free; Ambion). cDNA was generated using oligo(dT) and SuperScript II reverse transcriptase (Invitrogen). Quantitative real-time PCR was performed using SYBR Green MasterMix (Applied Biosystems) on an ABI Prism 7500 system (PerkinElmer) and evaluated with 7500 System Software. Specificity of PCR was monitored with melting curve analysis, and amplification of a single product of the expected size was verified on agarose gels in initial experiments. Relative expression was normalized to GAPDH. For quantitative RT-PCR the following primers were used: BLIMP-1 forward (5Ј-ACCAAGGAATCTGCTTTTCAAGTATG-3Ј), BLIMP-1 reverse (5Ј-CA TCACTCCAATAACCTCTTCACTGT-3Ј); C/EBP homologous protein (CHOP)/GADD153 forward (5Ј-TGGAAGCCTGGTATGAGGAC-3Ј), CHOP/GADD153 reverse (5Ј-TGTGACCTCTGCTGGTTCTG-3Ј); DNAJB9 forward (5Ј-AGTCGGAGGGTGCAGGATATT-3Ј), DNAJB9 reverse (5Ј-CC GATTTTGGCACACCTAA-3Ј); IDO1 forward (5Ј-GCCCTTCAAGTGTT TCACCAA-3Ј), IDO1 reverse (5Ј-GCCTTTCCAGCCAGACAAAT AT-3Ј); GAPDH forward (5Ј-AACAGCGACACCCACTCCTC-3Ј), GAPDH reverse (5Ј-CATACCAGGAAATGAGCTTGACAA-3Ј).
X-box binding protein 1 (XBP-1) mRNA splicing was monitored using 5Ј-CTGAAGAGGAGGCGGAAGC-3Ј (forward) and 5Ј-AATACCGCCA GAATCCATGG-3Ј (reverse) primers in conventional PCR reactions using AmpliTaq Gold (Applied Biosystems).
Luciferase vectors and assays
The promoter sequence of the human IDO1 locus was amplified from genomic DNA with the following primers: IDO1 FL (forward) (5Ј-TATA AGATCTCAGAATCATCTAAAACG-3Ј), IDO1 short (forward) (5Ј-TATA AGATCTAGCCTTCATTTTCATTC-3Ј), IDO1 (reverse) (5Ј-AATTAAG CTTCTTATAATAGTTGCTGC-3Ј).
The amplicons were then cloned into the vector pXPG (40) generating promoter constructs spanning Ϫ1298 to ϩ52 for IDO1 FL and Ϫ272 to ϩ52 for IDO1 short, relative to the transcriptional start sites of reference sequences. Mutations were introduced into the short IDO1 promoter using the Gene Tailor site-directed mutagenesis kit (Invitrogen) as shown in Fig.  5 using the following primers, with the mutated residues underlined: IDO1 mutant 1 (forward) (5Ј-AAAATGAAACCATTCCAAAACTGGAACTA ATTTCTCAC-3Ј), IDO1 mutant 1 (reverse) (5Ј-TTTTGGAATGGTTTCA TTTTCTAGTTTCTT-3Ј), IDO1 mutant 2 (forward) (5Ј-ACAAACAAAG AAACTAGAAACTGAAACCATTC-3Ј), IDO1 mutant 2 (reverse) (5Ј-TT TCTAGTTTCTTTGTTTGTAATATGAAAACC-3Ј). Mutant 2 was derived from the mutant 1 plasmid, and all constructs were sequence verified before use. For luciferase assays, three replicate transfections were performed for each condition. Experiments were done using the Promega luciferase assay system and analyzed on a Berthold Lumat LB luminometer. Each experiment was performed in duplicate with similar results and was confirmed with separate plasmid preparations. The data are from a representative experiment displayed as fold increase in light units relative to unstimulated cells cotransfected with the empty vector.
Antibodies
Rabbit antisera to BLIMP-1 have been described previously (25, 31) . Rabbit polyclonal Abs to IRF-1 and IRF-2 were from Santa Cruz Biotechnology. Nonimmune rabbit IgG was from Upstate Biotechnology. Abs used for flow cytometry were monoclonal anti-human CD14 conjugated to PE (Dako) and monoclonal anti-human CD11b conjugated to PE (BD Biosciences). Rabbit polyclonal Ab to GCN2 was from Cell Signaling Technology, and mouse mAb to ␤-actin, clone AC15, was from Sigma-Aldrich.
EMSA
Nuclear extracts were prepared from COS7 cells transfected with expression vectors for BLIMP-1, IRF-1, or IRF-2 as described previously (30) . For EMSA, the double-stranded probes used contained the extended IFNstimulated response element (ISRE) sequence in the proximal region of the IDO1 promoter within the following sequences: IDO1 wild-type (wt) (forward) (5Ј-ACAAACAAAGAAACTAGAAAATGAAACCATTCCAAA AGTGGAAGTAATTTCTCACTGCCC-3Ј), IDO1 wt (reverse) (5Ј-GGGC AGTGAGAAATTACTTCCACTTTTGGAATGGTTTCATTTTCTAGTT TCTTTGTTTGT-3Ј). The underlined bases represent sites in which positions of the ISRE sites were altered as described in Fig. 5 .
DNA probes [ 32 P] labeled with T4 polynucleotide kinase were incubated with nuclear extract in the presence of poly(dI:dC) (Amersham Biosciences) for 30 min at room temperature. Supershift was performed by the addition of antisera to the extract before mixing with radioactive probe, and competition assays included the addition of unlabeled probe to the reaction mixture.
Chromatin immunoprecipitation (ChIP)
Chromatin prepared from myeloma cells or primary monocytes was precipitated with 2-4 g of Ab to BLIMP-1, IRF-1, IRF-2, or control rabbit Ab and protein A-Sepharose. DNA was eluted and cross-links were reversed by overnight incubation at 65°C. Input DNA was prepared from an equal volume of chromatin following RNase treatment and resuspended in the same final volume as the ChIP samples. A standard curve of input DNA was generated from each chromatin sample. Target sequences were analyzed by real-time PCR as described above. The amount of precipitated material was calculated from the standard curve and normalized relative to control immunoprecipitates. The data are representative of a minimum of two independent chromatin preparations, and they represent average and SD of at least two independent immunoprecipitations. The following primers were used: IDO1 Ϫ1449 (forward)
Protein analysis
Equivalent numbers of U937 cells were treated as indicated, then washed with PBS and lysed in reducing Laemmli buffer. Samples were separated on SDS-PAGE, transferred to nitrocellulose, and blocked in Tris-buffered saline containing 1% BSA and 0.1% Tween 20. Abs used to detect BLIMP-1, GCN2, and ␤-actin were incubated with the membrane followed by secondary Abs coupled to HRP and visualized using an ECL (Pierce) protocol.
Results
The GCN2 activator tryptophanol induces BLIMP-1 BLIMP-1 is rapidly expressed following PMA stimulation of U937 monocytic cells and is involved in the differentiation of this cell line (41) . Furthermore, we have shown that U937 cells subjected to a range of stimuli that target ER stress response pathways induce BLIMP-1 at the level of transcription (25) .
To assess whether BLIMP-1 is also responsive to stress pathways initiated by nutritional deprivation, U937 cells were treated with the amino acid alcohol tryptophanol. Amino acid alcohols act as competitive substrates for tRNA synthetases, thus inhibiting the aminoacylation of tRNAs. GCN2 is subsequently activated by the resulting increase in uncharged tRNA (19) . For comparison, U937 cells were also treated with PMA or DTT, a potent inducer of the unfolded protein response.
A kinetic analysis of BLIMP-1 induction confirmed previous results, demonstrating a gradual increase in response to PMA stimulation that was maintained throughout the time course, whereas DTT stimulation generates an ϳ6-fold increase in transcript level that peaks between 4 and 6 h and then declines (Fig. 1A) (25) . Tryptophanol treatment of U937 also increased BLIMP-1 mRNA levels in a pattern that was most similar to that observed with DTT. To control for the specificity of each stimulus, other stress-induced genes were analyzed in the same samples. CHOP represents a common target of eIF2␣ kinases and was elevated to similar levels as BLIMP-1 in response to both DTT and tryptophanol, but not to PMA (13) . In contrast, DNAJB9 is a specific target of the ER stress response pathway and accordingly is only up-regulated in response to DTT (42) . As an additional marker of the unfolded protein response, we evaluated XBP-1 mRNA splicing, which was also confined to DTT-stimulated samples (Fig. 1C) (43, 44) . These results confirm that tryptophanol does not induce a stress response via the ER pathway.
To demonstrate that the response observed in U937 cells was not a property unique to this monocytic cell line, we evaluated BLIMP-1 levels in primary human monocytes purified from peripheral blood (Fig. 1B) . Samples from five healthy individuals were subjected to stimulation with tryptophanol. After 6 or 24 h of incubation the levels of BLIMP-1 and CHOP mRNA were assessed. In each case, the basal levels of CHOP were reduced by prolonged incubation without stimulation. However, treatment with tryptophanol increased the relative amount of CHOP at each time point. BLIMP-1 levels remained essentially unchanged in samples treated with media alone for 6 h, but showed a reproducible 2-to 3-fold increase in the tryptophanol-treated samples over the same time frame. At 24 h a similar increase was maintained in tryptophanol-treated samples relative to samples treated with media alone at the same time point, although absolute levels had returned to starting levels.
The above data show that BLIMP-1 mRNA is rapidly up-regulated in response to both ER stress and an activator of GCN2. We had previously shown that BLIMP-1 protein expression is delayed during the DTT stress response, similar to stress response genes such as BiP (GRP78) (25, 45) . To determine whether induction of BLIMP-1 in response to tryptophanol leads to a similar delay in translation, lysates were prepared from U937 cells treated for the indicated amount of time and evaluated for BLIMP-1 protein (Fig.  1D) . As anticipated, PMA stimulation of U937 results in BLIMP-1 protein induction that is entirely concordant with the levels of mRNA, whereas tryptophanol treatment gives rise to abundant protein at a later time point. These results indicate that BLIMP-1 is transiently expressed when aminoacyl-tRNA formation is prevented.
IDO1-mediated tryptophan depletion induces BLIMP-1
Pharmacological agents such as DTT and tryptophanol offer a convenient means for eliciting a robust stress response, but may not fully recapitulate the same response to a physiological stimulus in vivo. To better approximate the effect of amino acid deficiency on BLIMP-1 induction, we generated tryptophan-deficient media by transfecting HeLa cells with an expression vector encoding the human IDO1 gene. HPLC analysis of the resulting conditioned media confirmed the selective depletion of tryptophan in the presence of IDO1-expressing cells, reducing the detectable concentration from 5 g/ml in standard media to 0.37 Ϯ 0.01 g/ml (Fig.  2A) . The observed reduction in tryptophan levels between empty vector and IDO1-conditioned media was 83 Ϯ 8.5%, determined from three independent preparations. U937 cells were cultured for 24 h in conditioned media derived from HeLa cells transfected with empty vector or an IDO1 expression vector (Fig. 2B) . Transcripts for both BLIMP-1 and CHOP increased 4-fold in cells incubated with the IDO1-conditioned media, while DNAJB9 levels remained unaffected. The catabolism of tryptophan by IDO1 not only lowers the available concentration of this essential amino acid, but it also results in generation of biologically active metabolites from the kynurenine pathway (9, 10). To determine whether tryptophan depletion was the predominant activity leading to enhanced gene expression, the conditioned media were supplemented with a 10-fold excess (10ϫ) of the normal concentration of Ltryptophan. Inclusion of excess tryptophan completely abolished induction of BLIMP-1 and CHOP in the presence of IDO1-conditioned media, indicating that the absence of free tryptophan is essential for this response, as opposed to the generation of kynurenine metabolites.
To confirm that the increased levels of BLIMP-1 mRNA obtained in U937 cells exposed to tryptophan-depleted media were mirrored in BLIMP-1 protein levels, we performed Western blot analysis on the same samples. Incubating U937 cells with media from HeLa cells transfected with empty vector had no effect on BLIMP-1 levels (Fig.  2C) . In contrast, cells grown in media from IDO1-transfected HeLa cells increased BLIMP-1 protein, while inclusion of supplemental tryptophan restored the protein to basal levels.
FIGURE 1. GCN2 activation by tryptophanol increases BLIMP-1 expression in U937 cells and primary monocytes. A, BLIMP-1, CHOP, and DNAJB9
mRNA levels were determined by quantitative RT-PCR relative to GAPDH in U937 cells cultured in the presence of 0.5 mM tryptophanol, 2 mM DTT, 10 ng/ml PMA or media alone for the indicated times. These data are derived from a minimum of three separate experiments and are displayed as the means Ϯ SD. B, The expression of BLIMP-1 and CHOP mRNA was assessed by quantitative RT-PCR in primary human monocytes treated with 1 mM tryptophanol or media alone for the indicated times. These data are derived from five healthy donors and are normalized to expression in a 0-h control from each individual. The mean value from the five samples is indicated on the plot ‫,ءء(‬ p Ͻ 0.01 and ‫,ء‬ p Ͻ 0.05 by unpaired t test). C, XBP-1 splicing (U, unspliced; S, spliced) was assessed in the samples described in A by conventional RT-PCR. D, The kinetics of BLIMP-1 protein expression in U937 cells after stimulation with 0.5 mM tryptophanol or 10 ng/ml PMA was assessed by Western blotting.
To further substantiate these observations, we subjected primary human monocytes to culture with media derived from transfected HeLa cells. Consistent with the results obtained from U937 cells, primary monocytes exposed to IDO1-conditioned media showed a reproducible induction of BLIMP-1, as well as an expected increase in CHOP, relative to cells cultured with media from empty vector transfectants (Fig. 2D) . Supplementation of IDO1-conditioned media with excess tryptophan once again prevented the response. Thus, a tryptophan-depleted microenvironment generated by expression of IDO1 is sufficient to induce BLIMP-1.
Induction of BLIMP-1 mRNA is dependent on GCN2
The induction of BLIMP-1 by tryptophanol and tryptophan depletion implicates GCN2 as a key mediator of the response. To directly address this we therefore examined the effect of depleting GCN2 expression on BLIMP-1 induction. Transfection of U937 cells with GCN2-specific but not control siRNA resulted in knockdown of GCN2 protein expression (Fig. 3A) . To determine whether induction of BLIMP-1 is downstream of GCN2 in the amino acid stress response, the mRNA levels of BLIMP-1 and CHOP were then assessed in these cells after treatment with IDO1-conditioned media (Fig. 3B) . While cells treated with control siRNA induced the genes encoding BLIMP-1 and CHOP when subjected to tryptophan depletion, in cells expressing low levels of GCN2 protein, the induction of both BLIMP-1 and the stress response gene CHOP was abolished. Thus, the induction of BLIMP-1 mRNA by tryptophan-deficient media is dependent on a functional GCN2 signaling pathway.
BLIMP-1 binds to regulatory regions in the IDO1 promoter
Expression of IDO1 in multiple cell types is modulated in response to local inflammatory signals, most notably IFN-␥ and IFN-␣ (7, 46, 47) . The recruitment of STAT1 and IRF-1 to the IDO1 promoter mediates the potent response to IFN-␥, and animals deficient in either IRF-1 or IFN-␥ fail to produce IDO1 during infection (48, 49) . We have previously shown that the transcriptional repressor BLIMP-1 is an effective competitor for binding to sites that are alternatively occupied by IRF-1 or IRF-2 (30, 31) . To determine whether BLIMP-1 is capable of binding to the IDO1 promoter in vivo, we performed ChIP from myeloma cell lines, which express constitutively high levels of BLIMP-1 protein. An earlier characterization of the IDO1 promoter identified two ISREs located Ϫ1050 and Ϫ30 bp upstream of the transcriptional start site that contain potential IRF binding sites (50) . Evaluation of BLIMP-1 binding to a region spanning both sites with a series of primer pairs revealed a preferential 6-to 10-fold association with the proximal ISRE in both cell lines (Fig. 4A ). These myeloma cell lines also constitutively express both IRF-1 and IRF-2, which can compete with BLIMP-1 for binding site occupancy. ChIP analysis of IRF-1 and IRF-2 binding to the IDO1 promoter region demonstrated a similar pattern of occupancy to that of BLIMP-1 (Fig. 4,  B and C) . There was no detectable enrichment at the distal ISRE with any of these transcription factors.
To demonstrate that BLIMP-1 inducibly expressed in the myeloid lineage can also bind to the IDO1 promoter, we performed ChIP from primary human monocytes that had been cultured in the presence of tryptophanol for 6 h (Fig. 4D) . BLIMP-1 demonstrated an ϳ2-fold enrichment using primer pairs closest to the predicted binding site. Assessment of binding using additional primers that amplify within the coding region of the IDO1 gene showed no enrichment. Thus, the ability of BLIMP-1 to bind the IDO1 promoter is maintained, whether it is constitutively or inducibly expressed, and is observed in a cell type in which IDO1 normally functions.
The region of the human IDO1 promoter where we detected BLIMP-1 binding contains a characterized ISRE motif that confers IFN responsiveness (46) . In addition to this known site, a more degenerate sequence that is similar to an ISRE motif is present immediately downstream (Fig. 5B) . Examination of these sequences suggested that, although divergent from the optimum BLIMP-1 consensus, the tandem sites may be sufficient to confer BLIMP-1 binding (29) . Using a probe that incorporated both potential ISREs, we evaluated the relative binding of BLIMP-1, IRF-1, and IRF-2 by EMSA (Fig. 5A) . A single dominant band was observed for all three proteins consistent with monomeric interactions. The specificity of these complexes was confirmed by Ab supershift. A higher molecular mass species, possibly representing two molecules, was observed with BLIMP-1-containing nuclear extract.
We had previously found that BLIMP-1 exhibits a strong preference for a G rather than C at key positions of overlapping BLIMP-1/IRF binding sites (30, 31) . The presence of a C at one of the equivalent positions in the upstream ISRE suggested that the downstream motif could be more relevant to BLIMP-1 binding. To assess the contribution of this site we performed a competitor assay using excess unlabelled probe in which the indicated G residues were mutated to Cs (mutant 1, Fig. 5B ). As expected, the introduction of these mutations had no effect on the binding of either IRF-1 or IRF-2. However, BLIMP-1 binding was not abolished but only slightly reduced. This suggested that binding to the upstream ISRE was indeed important. We therefore assayed a probe containing a further unfavorable base substitution in this upstream site (mutant 2, Fig. 5B ). While IRF-1 and IRF-2 binding were modestly affected by the alteration, this change was sufficient to block competition for BLIMP-1 binding. These results indicate that greater divergence from the optimal consensus is tolerated by BLIMP-1 at this tandem binding site.
BLIMP-1 represses IDO1 promoter induction
To address whether BLIMP-1 regulates the IDO1 promoter as predicted by promoter binding, we generated luciferase reporter constructs. In the first instance, we evaluated a construct that contained the basal promoter and the single proximal ISRE (short IDO1). Stimulation of transfected HeLa cells with IFN-␥ for 6 h resulted in a 16-fold increase in luciferase activity relative to cells treated with media alone (Fig. 6A) . Cotransfection of a vector encoding BLIMP-1 inhibited the IFN-␥ response by Ͼ4-fold. To determine whether BLIMP-1 could operate in the presence of additional upstream regulatory elements, we generated a construct that included the distal ISRE as well as an IFN-responsive IFN-␥ activation site (GAS) element (FL IDO1) (48, 50) . IFN-␥ stimulation of HeLa cells transfected with this construct produced a 300-fold induction of the reporter gene, reflecting co-operation between the multiple cis-regulatory elements. Cotransfection of BLIMP-1 had a profound effect on the IFN-␥ induction, reducing the stimulation by Ͼ10-fold.
Although IFN-␥ is generally the most potent inducer of IDO1 expression, the type I IFN IFN-␣ has also been shown to regulate this gene (46, 47) . Examination of the response of the luciferase constructs to IFN-␣ stimulation showed an 8-fold induction of the FL reporter and a weaker activation of the short construct (Fig.  6B) . The inclusion of the BLIMP-1 expression vector substantially reduced the luciferase activity driven by either promoter.
To further determine the importance of the BLIMP-1 binding, we performed site-directed mutagenesis of the short IDO1 promoter containing the proximal ISRE and overlapping BLIMP-1 binding site. Equivalent mutations were introduced into the critical residues of the extended BLIMP-1 site as defined by EMSA (Fig. 5) . The response to IFN-␥ was retained after mutation of either one or both halves of the extended BLIMP-1 binding site, although efficiency of induction was somewhat reduced (Fig.  6C) . As predicted by EMSA, cotransfection of BLIMP-1 also inhibited mutant 1 where only the first half of the extended site retains preferred residues for BLIMP-1 binding, although the retained inhibition is not as effective as that seen on the wt promoter. Mutation of both halves of the extended ISRE/ BLIMP-1 site in mutant 2 was required to eliminate BLIMP-1-dependent repression. Taken together, these results indicate that BLIMP-1 binds to and regulates the IDO1 promoter and provide further evidence to suggest that some promoters containing tandem BLIMP-1 sites allow greater divergence from the optimal consensus sequence.
BLIMP-1 prevents IFN-␥-dependent induction of endogenous IDO1
To ensure that the observed inhibition of the IDO1 promoter construct by BLIMP-1 could be reproduced in the context of the native promoter, we evaluated regulation of the endogenous gene. HeLa cells were transfected with bicistronic BLIMP-1-EGFP or control EGFP vector and EGFP high -expressing cells were sorted (Fig. 7) . The transfected populations were treated with IFN-␥, and the relative expression levels of IDO1 mRNA were measured after 6 or 24 h. Cells transfected with the empty vector substantially increased IDO1 levels after 6 h of treatment with IFN-␥ (100% relative induction), and levels remained high at the 24 h time point. In contrast, cells that expressed BLIMP-1 generated Ͻ20% of the amount of IDO1 expressed by control cells at 6 h. At 24 h, the levels of IDO1 remained substantially suppressed, although to a somewhat lesser extent. Thus, consistent with the demonstration of direct promoter regulation detailed above, BLIMP-1 represses the IFN-␥ response of the endogenous IDO1 gene.
Discussion
The original identification of BLIMP-1 as a repressor of IFN-␤ during viral infection provides a groundwork for establishing how this transcription factor may be functioning outside the B cell lineage during inflammatory and immune responses (26) . In contrast to the requirement for sustained BLIMP-1 expression in the generation and maintenance of plasma cells, exposure of other cell lineages to acute stimuli may lead to a transient increase in BLIMP-1 protein to repress genes likely to impact on the cell's responsive behavior (51) . Our previous data identified BLIMP-1 as a gene that is induced downstream of the kinase PERK after exposure of cells to agents that initiate a stress response of the endoplasmic reticulum (25) . Since PERK is one of four kinases that converges on eIF2␣, and another of these, protein kinase R, is activated during viral infection, we hypothesized that BLIMP-1 may represent a transcription factor that is selectively induced during cellular stress. We now show that an additional pathway leading to eIF2␣ phosphorylation, triggered by low levels of an essential amino acid, can stimulate BLIMP-1 expression through activation of the stress kinase GCN2.
The identification of BLIMP-1 as a molecular target of IDO1-mediated GCN2 activation not only reinforces the concept that BLIMP-1 should be considered as a transcriptional regulator of the integrated stress response, but also highlights its recurring role in the feedback attenuation of cellular responses. For example, a recent report documenting the function of BLIMP-1 in the T cell lineage demonstrated that upon activation of mature T cells, IL-2 drives the late induction of BLIMP-1 and then is itself extinguished as BLIMP-1 protein accumulates (52) . These kinetics contrast with the acute induction observed in response to cell stress, indicating that the timing of BLIMP-1 expression is very much cell-type and stimulus specific. This may in turn translate into differential effects on target gene regulation. Our results show that the activation of GCN2, in the absence of other stimulatory inputs, results in the rapid induction of BLIMP-1 in monocytes. In another setting, the activation of GCN2 in CD19 ϩ dendritic cells stimulated through B7 ligation leads to an amplification of IDO1 (20) . In this instance the dynamics of IDO1 expression may be far more complex, requiring the coordinated activity of a series of different transcription factors to achieve the desired outcome.
The IDO1 gene is evolutionarily ancient and is likely to have evolved from an enzyme used by unicellular organisms competing for limiting nutrients, to one used by an intermediate immune system checking the growth of pathogens, to one used by a sophisticated higher vertebrate such as placental mammals where IDO1 is involved in regulatory networks integrating both innate and adaptive immune systems (10) . As part of the evolutionary process, the IDO1 gene has acquired the ability to respond to signals specific to the adaptive immune system. Most notably, the IDO1 promoter is highly responsive to IFN-␥ and requires the action of the transcription factor IRF-1 (48, 49) . The closely related IDO2 gene is also responsive to IFN-␥ in a number of cell lines, but not in a murine model of malaria infection in which IDO1 expression depends on IFN-␥ (36 -39). The ability of IRF-1, and potentially BLIMP-1, to modulate IDO2 will require a more thorough investigation of the regulatory elements governing expression of this locus. In agreement with the previous descriptions of BLIMP-1 as an antagonistic regulator of IRF-1-bound promoters, the data presented herein identify the IDO1 promoter as belonging to this group as well (29 -31) . Indeed, IDO1 may represent a target that exemplifies how the regulatory module of BLIMP-1 and IRF transcription factors was reused as the immune system developed (31) .
In addition to its ability to compete with the IRF family of transcription factors, BLIMP-1 can also recruit epigenetic modifiers to repress target loci. Among the growing number of BLIMP-1 epigenetic partners are histone deacetylases 1 and 2 (32, 35) . While displacement of IRF-1 by BLIMP-1 at the IDO1 promoter may be sufficient to down-regulate expression, histone modification, and deacetylation in particular, could contribute to maintaining appropriate IDO1 levels. Notably, histone deacetylase inhibitors were recently shown to induce IDO1 in dendritic cells, resulting in suppression of inflammation in a model of graft-vshost disease (53) .
Although the IDO1 promoter contains two potential sites for BLIMP-1/IRF counterregulation, we observed preferential binding to the proximal ISRE site in myeloma cell lines. This does not exclude a role for the distal site in the regulation of IDO1, but suggests that it is either not operative in these cells or is potentially occupied by other factors. Moreover, the distal ISRE sequence contains C residues at both critical positions for BLIMP-1 binding, and it is unlikely to bind BLIMP-1 with high affinity. Given these findings, we focused our analysis on the proximal ISRE. A detailed inspection of the sequence demonstrated two potential BLIMP-1 binding sites adjacent to each other, immediately upstream of the IDO1 transcription start site. This element may therefore provide a platform for co-operative or multimeric binding, leading to enhanced transcriptional repression. Alternatively, the extended sequence may be engaging additional zinc finger domains of BLIMP-1 other than those that have been previously described. The available data suggest that only the first two of five zinc finger domains of BLIMP-1 are responsible for contacting the positive regulatory domain I (PRDI) site within the IFN-␤ promoter (54) . Whether this holds true for all BLIMP-1 targets has not been rigorously tested. However, the presence of a high-molecular mass complex in the EMSA in Fig. 5A and the graded inhibition of BLIMP-1-mediated repression observed when mutating one or both potential BLIMP-1 binding sites in the extended proximal ISRE site in Fig. 6C suggest that co-operative binding is more likely.
The finding that BLIMP-1 has the potential to modulate IDO1 expression opens up the possibility that BLIMP-1 plays a more expansive role during immune suppression. There are a number of lines of evidence documenting cell-autonomous effects of IDO1 on gene expression in APCs, including the alteration of metalloprotease expression and prostaglandin synthesis (55) . The transient expression of BLIMP-1 in these cells could repress other genes required for effective Ag presentation. Our previous work demonstrating the repression of components of both MHC class I and class II Ag presentation pathways by BLIMP-1 is consistent with this suggestion (30, 31) .
Furthermore, when one considers the wider immune context in which monocytic cells are expressing IDO1 in response to IFN-␥, tryptophan is depleted not just from the IDO1-expressing cell, but also from the surrounding tissue microenvironment. As a result, neighboring cells will also be subjected to inadequate levels of free tryptophan. In particular, T cells are exposed to this microenvironment as they are recruited to participate in the immune response. T cell proliferation is known to be susceptible to the effects of enzymes expressed by APCs that catabolize and lower concentrations of amino acids, such as tryptophan and arginine, in mixed leukocyte reactions (19, 56) . With respect to IDO1, this is in part due to an amino acid stress response since proliferation can be restored through the addition of excess tryptophan (5, 19) . Moreover, the starvation stress response in T cells is GCN2 dependent, since GCN2-knockout T cells are both resistant to the effects of IDO1 and fail to differentiate into regulatory T cells (11, 19) . At present, the downstream components linking GCN2 to the attenuation of T cell responses remain uncharacterized. However, the fate of effector and regulatory T cells is controlled and rerouted through the expression of BLIMP-1 (57, 58) . Thus, in cells of both the monocytic and T cell lineages, the stress-mediated up-regulation of BLIMP-1 may contribute more widely to the immunoregulatory effects of the IDO1-GCN2 axis.
